Drug Trial Radar · NCT00379821
Chloroquine Alone or in Combination for Malaria in Children in Malawi
Last checked: Nov 20, 2026Latest source record: Aug 11, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
640
Actual
Start
Feb 2007
Primary completion
Aug 2009
Study completion Sep 2012
Sponsor
- Sponsor type
- NIH
- First posted
- Sep 25, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 6 months, up to 5 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Malaria is a sickness caused by a germ that can get into a person's body when a mosquito bites them. It can cause fever, headache, body aches and weakness. It can even cause death, especially in children. When malaria is treated with the appropriate medicine(s), it can be cured completely. The purpose of this study is to find out if it is better to use chloroquine alone or in combination with another drug to most effectively treat malaria. About 640 children with malaria, aged 6 months to 5 years of age, from the Blantyre Malaria Project Research Clinic at the Ndirande Health Center in Malawi will be in the study. They will be treated with either chloroquine alone or a combination of chloroquine plus another medication (azithromycin or artesunate or atovaquone-proguanil) every time they get malaria for a year. Blood samples will be collected and tested at least every 4 weeks. Participants will be involved in the study for 1 year.
Conditions
- Plasmodium Falciparum Infection
Interventions
Atovaquone-proguanilDrug
Atovaquone-proguanil: once a day for 3 days, Pediatric tablet: 62.5 mg/25 mg, Full strength tablet: 250 mg/100 mg
ArtesunateDrug
Artesunate: 4mg/kg once a day for 3 days, 50 mg tablet
AzithromycinDrug
Azithromycin 30 mg/kg once a day for 3 days, 200 mg/5cc suspension
ChloroquineDrug
Chloroquine: 10 mg/kg on days 0 and 1, 5 mg/kg/day on day 2, 100 mg tablet.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Clinical Malaria Episodes Per Year of Follow-upTime frame: 1 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Blantyre Malaria Project - Ndirande Health Centre
Blantyre, Blantyre, Malawi
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.